spacer spacer  
  spacer
 
underline
spacer


Jointly Sponsored by:

pim-logo        asim-logo

This activity is supported by an educational grant from Merck and Company.
banner
 
underline
spacer
 
  • Pittsburgh, PA - (Aug 28, 2007)
  • Las Vegas, NV - (Sep 12, 2007)
  • Chicago, IL - (Aug 29, 2007)
  • New York, NY - (Oct 2, 2007)
  • Washington, DC - (Aug 30, 2007)
  • Boston, MA - (Oct 3, 2007)
  • Atlanta, GA - (Sep 5, 2007)
  • Dallas, TX - (Oct 16, 2007)
  • Philadelphia, PA - (Sep 6, 2007)
  • Houston, TX - (Oct 17, 2007)
  • Los Angeles, CA - (Sep 11, 2007)
  • Tampa, FL - (Oct 18, 2007)
  •  
    underline
    spacer
     

    Nosocomial (hospital-acquired) bloodstream infections continue to complicate the clinical course of critically ill patients and, consequently, to create substantial economic and human costs. These infections may lead to complications in approximately 30% of those patients admitted to an intensive care unit (ICU) and cost an estimated $25,000 per infection. Previous studies have shown that administration of inadequate antimicrobial treatment of bloodstream infections is associated with significantly higher mortality rate; therefore, strategies to limit bloodstream infections in the ICU have been developed to improve patient outcomes. Although healthcare providers are cognizant of measures to control infection, inconsistent application of these measures remain a concern in the ICU.

    In this regional dinner meeting, we will present up-to-date information on the risk of acquiring nosocomial bloodstream infections, highlight the most common sites of these infections, and discuss strategies for preventing and controlling bloodstream infections in the ICU. The goals are to enhance awareness and understanding of risks for bloodstream infection and encourage consistent application of infection control measures to promote more favorable outcomes for patients.

     
    underline
    spacer
      George Karam, MD
    Louisiana State University School of Medicine
    New Orleans, LA
    Marin H. Kollef, MD
    Washington University School of Medicine
    St. Louis, MO
       
     
    underline
    spacer
      After completing this activity, the participant should be better able to:
    • Identify patients at risk for bloodstream infections and multiple drug-resistant pathogens in the ICU
    • Describe the epidemiology of bloodstream infections
    • Outline an approach to the prevention and treatment of bloodstream infections
    • Explain issues with adequate empiric therapy and the morbidity/mortality associated with inadequate treatment
    • Describe de-escalation therapy and its implementation into clinical practice
       
     
    underline
    spacer
     

    Registration and Dinner (30 Minutes)

    Introduction and Overview (5 Minutes)
    Local Moderator

    Management of Invasive Fungal Infections in the ICU (25 Minutes)
    Marin Kollef, MD

    The Evolving Response to Antibiotic Resistance in the ICU (25 Minutes)
    George Karam, MD

    Question and Answer Session (30 Minutes)

    Program Conclusion (5 Minutes)
    Local Moderator

       
     
    underline
    spacer
     

    Intended Audience
    Infectious disease physicians, hospitalists, internal medicine physicians, critical care and intensive care physicians, and fellows (surgical and medical); hospital pharmacists, ICU PharmDs, and hospital formulary committee directors.

    Physician Continuing Medical Education
    Accreditation Statement
    This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Advanced Studies in Medicine (ASiM). PIM is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation
    Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Pharmacist Continuing Education
    acpe logoAccreditation Statement
    Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    Credit Designation
    Postgraduate Institute for Medicine (PIM) designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within 3 weeks.
    (Universal Program Number – 809-999-07-071-L01.)

    Disclosure of Conflicts of Interest
    Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    Fee Information
    There is no fee for this educational activity.

       
     
    spacer  
      spacer
    Advanced Studies in Medicine © 2011 Contact Us
    spacer  
    spacer